BrainCo files for Hong Kong IPO — first BCI company to pursue public markets after $286M Series C
Summary
BrainCo, the Chinese non-invasive BCI and bionic limb company, has filed for a Hong Kong Stock Exchange IPO following its $286M Series C raise in January 2026. The IPO filing makes BrainCo the first dedicated BCI company to pursue public markets globally. The company's non-invasive EEG-based products span education technology, rehabilitation, and human performance applications across China, with significant revenue from its bionic hand business.
Why it matters
A BrainCo Hong Kong IPO would be the first public market listing of a dedicated BCI company, creating a public valuation benchmark for the entire sector. Even with no revenue from the most ambitious BCI applications, BrainCo's EEG and bionic limb revenues give it the commercial track record needed for public market listing.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial